Extracellular vesicles as potential biomarkers and therapeutic approaches in autoimmune diseases

J Transl Med. 2020 Nov 12;18(1):432. doi: 10.1186/s12967-020-02609-0.

Abstract

Extracellular vesicles are heterogeneous populations of naturally occurring secreted small vesicles. EVs function as signaling platforms to facilitate intracellular communication, which indicates the physiological or pathophysiological conditions of cells or tissues. Considering that EVs can be isolated from most body fluids and that molecular constituents could be reprogrammed according to the physiological status of the secreting cells, EVs are regarded as novel diagnostic and prognostic biomarkers for many diseases. The ability to protect encapsulated molecules from degradation in body fluids suggests the potential of EVs as biological medicines or drug delivery systems. This article focuses on the EV-associated biomarkers and therapeutic approaches in autoimmune diseases.

Keywords: Autoimmunity; Biomarker; Exosomes; Extracellular vesicle; MicroRNA; Therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Autoimmune Diseases* / diagnosis
  • Autoimmune Diseases* / drug therapy
  • Biomarkers
  • Body Fluids*
  • Drug Delivery Systems
  • Extracellular Vesicles*
  • Humans

Substances

  • Biomarkers